Position in NPCE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,029,597
+$394,987 QoQ
Shares Held
127,728
+2.8% QoQ
Ownership
0.372%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 112 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NPCE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $556,179,741 across 31 Medical Devices names. NPCE ranks #19 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
5,343,777 | $228,072,401 | |
| 2 | SYK |
Stryker Corp
|
545,871 | $171,862,025 | |
| 3 | MDT |
Medtronic plc
|
922,752 | $72,186,888 | |
| 4 | DXCM |
Dexcom Inc
|
127,943 | $8,616,961 | |
| 5 | GMED |
Globus Medical Inc
|
103,160 | $8,150,671 | |
| 6 | TMDX |
TransMedics Group, Inc.
|
92,549 | $6,147,104 | |
| 7 | PODD |
Insulet Corp
|
35,853 | $5,458,619 | |
| 8 | LIVN |
LivaNova PLC
|
63,472 | $5,219,302 |
All Filings in NPCE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,029,597 | 127,728 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,634,610 | 124,305 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,748,224 | 113,227 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,083,467 | 105,089 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $878,778 | 78,885 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $38,086 | 3,099 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $38,124 | 3,407 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,886 | 3,427 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $25,900 | 3,426 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $46,741 | 3,541 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $40,507 | 3,929 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||